Instrumentation posts loss as it rebuilds in Italy:
This article was originally published in Clinica
Instrumentation Laboratory saw its losses continue in the first half of this year. Its sales fell to Lit212 billion ($123 million) from Lit228 billion. While it made a slightly smaller net loss for the half (Lit7 billion compared with Lit9 billion), the company expects poor trading conditions to continue to affect its margins. The Milan-based company said that competitive pressures in Italy, an unfavourable product mix and its attempt to rebuild its sales staff all contributed to the malaise.
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.